No Data
Bristol Myers Squibb Gets FDA Nod For Novel Multiple Myeloma Treatment
The U.S. Food and Drug Administration (FDA) on Thursday granted accelerated approval to Bristol Myers Squibb & Co.'s (NYSE:BMY) Zenbexus (iberdomide) for adult patients with multiple myeloma.The
Express News | Mubadala Investment Co Pjsc Cuts Share Stake in Gilead Sciences Inc by 19.9% to 29,623 Shares - SEC Filing
Express News | Mubadala Investment Co Pjsc Reports Share Stake of 23,405 Shares in Phillips 66 - SEC Filing
Express News | Mubadala Investment Co Pjsc Dissolves Share Stake in Medtronic PLC - SEC Filing
Express News | Mubadala Investment Co Pjsc Cuts Share Stake in Arm Holdings PLC by 34.5% to 901,960 Sponsored Ads - SEC Filing
Express News | Mubadala Investment Co Pjsc Raises Share Stake in AIG by 9.2% to 54,320 Shares - SEC Filing